Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 24;12(12):1171.
doi: 10.3390/metabo12121171.

The Role of Sphingolipids in the Pathogenesis of Psoriasis

Mateusz Matwiejuk  1 , Hanna Mysliwiec  1 , Adrian Chabowski  2 , Iwona Flisiak  1
Affiliations
Review

The Role of Sphingolipids in the Pathogenesis of Psoriasis

Mateusz Matwiejuk et al. Metabolites. .

Abstract

Psoriasis is a complex, chronic, immunologically mediated disease which involves skin and joints. Psoriasis is commonly connected with numerous other diseases such as liver diseases, metabolic syndrome, impaired glucose tolerance, diabetes mellitus, atherosclerosis, hypertension, and ischemic heart disease. Interestingly, comorbidities of psoriasis are an attention-grabbing issue. Additionally, it can cause impairment of quality of life and may be associated with depressive disorders. Altered levels of ceramides in psoriatic skin may lead to anti-apoptotic and pro-proliferative states, consequently leading to an over-proliferation of keratinocytes and the development of skin lesions. The pathophysiology of psoriasis and its comorbidities is not fully understood yet. Sphingolipids (including ceramides) and their disturbed metabolism may be the link between psoriasis and its comorbidities. Overall, the goal of this review was to discuss the role of sphingolipid disturbances in psoriasis and its comorbidities. We searched the PubMed database for relevant articles published before the beginning of May 2022. The systematic review included 65 eligible original articles.

Keywords: ceramide; ceramide S1P receptor; psoriasis; sphingolipid; sphingomyelin; sphingosine 1-phosphate; sphingosine kinase; sphingosine lipid signaling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Clinical picture of plaque psoriasis.
Figure 2
Figure 2
The search process.
See this image and copyright information in PMC

References

    1. Hannun Y.A., Obeid L.M. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 2017;19:175–191. doi: 10.1038/nrm.2017.107. - DOI - PMC - PubMed
    1. Kozłowska D., Harasim-Symbor E., Myśliwiec H., Milewska A., Chabowski A. Serum sphingolipid level in psoriatic patients with obesity. Adv. Dermatol. Allergol. 2019;36:714–721. doi: 10.5114/ada.2019.91422. - DOI - PMC - PubMed
    1. Łuczaj W., Wroński A., Domingues P., Rosário Domingues M., Skrzydlewska E. Lipidomic Analysis Reveals Specific Differences between Fibroblast and Keratinocyte Ceramide Profile of Patients with Psoriasis Vulgaris Molecules. Clin. Immunol. 2020;214:108397. doi: 10.1016/j.clim.2020.108397. - DOI - PMC - PubMed
    1. Myśliwiec H., Baran A., Harasim-Symbor E., Myśliwiec P., Milewska A.J., Chabowski A., Flisiak I. Serum fatty acid profile in psoriasis and its comorbidity. Arch. Dermatol. Res. 2017;309:371–380. doi: 10.1007/s00403-017-1748-x. - DOI - PMC - PubMed
    1. Checa A., Xu N., Sar D.G., Haeggström J.Z., Ståhle M., Wheelock C.E. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. PLoS ONE. 2019;14:e0216963. doi: 10.1038/srep12017. - DOI - PMC - PubMed

LinkOut - more resources